The DOI matches its Crossref record; 57 of the 58 references it cites were found in a registry or an index.
Cellular heterogeneity during mouse pancreatic ductal adenocarcinoma progression at single-cell resolution
Open accessPublished version of a preprint
Abstract
Pancreatic ductal adenocarcinoma (PDA) is a major cause of cancer-related death, with limited therapeutic options available. This highlights the need for improved understanding of the biology of PDA progression, a highly complex and dynamic process, featuring changes in cancer cells and stromal cells. A comprehensive characterization of PDA cancer cell and stromal cell heterogeneity during disease progression is lacking. In this study, we aimed to profile cell populations and understand their phenotypic changes during PDA progression. To that end, we used single-cell RNA–sequencing technology to agnostically profile cell heterogeneity during different stages of PDA progression in genetically engineered mouse models. Our data indicate that an epithelial-mesenchymal transition of cancer cells accompanies tumor progression in addition to distinct populations of macrophages with increasing inflammatory features. We also noted the existence of 3 distinct molecular subtypes of fibroblasts in the normal mouse pancreas, which ultimately gave rise to 2 distinct populations of fibroblasts in advanced PDA, supporting recent reports on intratumor fibroblast heterogeneity. Our data also suggest that cancer cells and fibroblasts may be dynamically regulated by epigenetic mechanisms. This study systematically describes the landscape of cellular heterogeneity during the progression of PDA and has the potential to act as a resource in the development of therapeutic strategies against specific cell populations of the disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The data gained through this approach suggests neoadjuvant treated patients would potentially respond better to adjuvant immunotherapy.”
From Pancreatic cancer: Advances and challenges (2023) · cites this paper as [268]
In the citing paper
“Illustrating this, a 36 marker CyTOF characterization of peripheral blood from PDAC patients revealed neoadjuvant FOLFIRINOX promotes an increase in effector T cells and concurrent decrease in suppressive immune populations268.”
From Pancreatic cancer: Advances and challenges (2023) · cites this paper as [268]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources
Huang, D. W., Sherman, B. T., & Lempicki, R. A. (2009) · Nature Protocols · doi:10.1038/nprot.2008.211 · Cited by 35,890
Integrating single-cell transcriptomic data across different conditions, technologies, and species
Butler, A., Hoffman, P., Smibert, P., Papalexi, E., & Satija, R. (2018) · Nature Biotechnology · doi:10.1038/nbt.4096 · Cited by 13,174
Massively parallel digital transcriptional profiling of single cells
Zheng, G. X. Y., Terry, J. M., Belgrader, P., Ryvkin, P., Bent, Z. W., Wilson, R., Ziraldo, S. B., Wheeler, T. D., McDermott, G. P., Zhu, J., et al. (2017) · Nature Communications · doi:10.1038/ncomms14049 · Cited by 7,353
Spencer, P. M., Cameron, J. L., & Lin, L. (2000) · Cited by 7,202
Super-enhancers in the control of cell identity and disease
Hnisz, D., Abraham, B. J., Lee, T. I., Lau, A., Saint-André, V., Sigova, A. A., Hoke, H. A., & Young, R. A. (2013) · Cell · doi:10.1016/j.cell.2013.09.053 · Cited by 3,662
Selective Inhibition of Tumor Oncogenes by Disruption of Super-Enhancers
Lovén, J., Hoke, H. A., Lin, C. Y., Lau, A., Orlando, D. A., Vakoc, C. R., Bradner, J. E., Lee, T. I., & Young, R. A. (2013) · Cell · doi:10.1016/j.cell.2013.03.036 · Cited by 2,961
Özdemir, B. C., Pentcheva-Hoang, T., Carstens, J. L., Zheng, X., Wu, C.-C., Simpson, T. R., Laklai, H., Sugimoto, H., Kahlert, C., Novitskiy, S. V., et al. (2014) · Cancer Cell · doi:10.1016/j.ccr.2014.04.005 · Cited by 2,681
Self-citationHingorani, S. R., Wang, L., Multani, A. S., Combs, C., Deramaudt, T. B., Hruban, R. H., Rustgi, A. K., Chang, S., & Tuveson, D. A. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.04.023 · Cited by 2,609
Distinct populations of inflammatory fibroblasts and myofibroblasts in pancreatic cancer
Öhlund, D., Handly-Santana, A., Biffi, G., Elyada, E., Almeida, A. S., Ponz-Sarvise, M., Corbo, V., Oni, T. E., Hearn, S. A., Lee, E. J., et al. (2017) · Journal of Experimental Medicine · doi:10.1084/jem.20162024 · Cited by 2,590
Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse
Hingorani, S. R., Petricoin, E. F., Maitra, A., Rajapakse, V., King, C., Jacobetz, M. A., Ross, S., Conrads, T. P., Veenstra, T. D., Hitt, B. A., et al. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00309-x · Cited by 2,471
Self-citation
Cited by
Sorted by citations
Items 101–200 of 296
Yan, W., Menjivar, R. E., Bonilla, M. E., Steele, N. G., Kemp, S. B., Du, W., Donahue, K. L., Brown, K. L., Carpenter, E. S., Avritt, F. R., et al. (2023) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-23-0037 · Cited by 52
Self-citationCancer immunotherapy via synergistic coactivation of myeloid receptors CD40 and Dectin-1
Wattenberg, M. M., Coho, H., Herrera, V. M., Graham, K. L., Stone, M. L., Xue, Y., Chang, R. B., Cassella, C. R., Liu, M., Choi-Bose, S., et al. (2023) · Science Immunology · doi:10.1126/sciimmunol.adj5097 · Cited by 53
A bird’s eye view of fibroblast heterogeneity: A pan‐disease, pan‐cancer perspective
Pradhan, R., Krishnamurty, A. T., Fletcher, A. L., Turley, S. J., & Müller, S. (2021) · Immunological Reviews · doi:10.1111/imr.12990 · Cited by 51
Mishra, S., Charan, M., Shukla, R. K., Agarwal, P., Misri, S., Verma, A. K., Ahirwar, D. K., Siddiqui, J., Kaul, K., Sahu, N., et al. (2022) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-021-02221-0 · Cited by 50
Guinn, S. R., Kinny‐Köster, B., Tandurella, J. A., Mitchell, J. T., Sidiropoulos, D. N., Loth, M., Lyman, M. R., Pucsek, A. B., Zabransky, D. J., Lee, J. W., et al. (2024) · Cancer Research · doi:10.1158/0008-5472.can-23-1660 · Cited by 47
Recent advances in understanding cancer-associated fibroblasts in pancreatic cancer
Huang, H., & Brekken, R. A. (2020) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00079.2020 · Cited by 49
Self-citationSkin fibroblast functional heterogeneity in health and disease
Bensa, T., Tekkela, S., & Rognoni, E. (2023) · The Journal of Pathology · doi:10.1002/path.6159 · Cited by 47
Pancreatic Fibroblast Heterogeneity: From Development to Cancer
Garcia, P. E., Scales, M. K., Allen, B. L., & di Magliano, M. P. (2020) · Cells · doi:10.3390/cells9112464 · Cited by 48
Xu, Q., Chen, S., Hu, Y., & Huang, W. (2021) · Cell Death Discovery · doi:10.1038/s41420-021-00663-1 · Cited by 47
Xu, Y., Li, W., Lin, S., Liu, B., Wu, P., & Li, L. (2023) · Cell Communication and Signaling · doi:10.1186/s12964-023-01204-2 · Cited by 50
Datta, J., Bianchi, A., Silva, I. D. C., Deshpande, N., Cao, L., Mehra, S., Singh, S. P., Rafie, C. I., Sun, X., Chen, X., et al. (2022) · Oncogene · doi:10.1038/s41388-022-02368-w · Cited by 46
Zuo, C., Baer, J. M., Knolhoff, B. L., Belle, J. I., Liu, X., de la Lastra, A. A., Fu, C. F., Hogg, G. D., Kingston, N. L., Breden, M. A., et al. (2023) · The Journal of Experimental Medicine · doi:10.1084/jem.20212062 · Cited by 43
Jakab, M., Rostalski, T., Lee, K. H., Mogler, C., & Augustin, H. G. (2022) · Cancer Research · doi:10.1158/0008-5472.can-21-3181 · Cited by 45
Tanaka, H. Y., Nakazawa, T., Enomoto, A., Masamune, A., & Kano, M. R. (2023) · Cancers · doi:10.3390/cancers15030724 · Cited by 42
A Quick Guide to CAF Subtypes in Pancreatic Cancer
Brichkina, A. I., Polo, P., Sharma, S. D., Visestamkul, N., & Lauth, M. (2023) · Cancers · doi:10.3390/cancers15092614 · Cited by 45
Huang, J., Tsang, W. Y., Li, Z., & Guan, X. (2023) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2023.07.001 · Cited by 42
Self-citationBehind the Wheel of Epithelial Plasticity in KRAS-Driven Cancers
Arner, E. N., Du, W., & Brekken, R. A. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.01049 · Cited by 40
Self-citationGenomic Heterogeneity of Pancreatic Ductal Adenocarcinoma and Its Clinical Impact
Gutiérrez, M. L., Muñoz‐Bellvís, L., & Órfão, A. (2021) · Cancers · doi:10.3390/cancers13174451 · Cited by 41
Medical Biology of Cancer-Associated Fibroblasts in Pancreatic Cancer
Morgan, A. G., Griffin, M., Kameni, L. E., Wan, D. C., Longaker, M. T., & Norton, J. A. (2023) · Biology · doi:10.3390/biology12081044 · Cited by 40
Cancer-Associated Fibroblast Diversity Shapes Tumor Metabolism in Pancreatic Cancer
Peiffer, R., Boumahd, Y., Gullo, C., Crake, R., Letellier, E., Bellahcène, A., & Peulen, O. (2022) · Cancers · doi:10.3390/cancers15010061 · Cited by 38
Cancer-Associated Fibroblasts: Lessons from Pancreatic Cancer
Sherman, M. H., & di Magliano, M. P. (2023) · Annual Review of Cancer Biology · doi:10.1146/annurev-cancerbio-061421-035400 · Cited by 39
Adem, B., Bastos, N., Ruivo, C. F., Sousa-Alves, S., Dias, C., Vieira, P. F., Batista, I. A., Cavadas, B., Saur, D., Machado, J. C., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-45753-7 · Cited by 37
Zhang, X., Zhu, R., Yu, D., Wang, J., Yan, Y., & Xu, K. (2023) · Cell Proliferation · doi:10.1111/cpr.13592 · Cited by 35
AXL Is a Key Factor for Cell Plasticity and Promotes Metastasis in Pancreatic Cancer
Du, W., Phinney, N. Z., Huang, H., Wang, Z., Westcott, J. M., Toombs, J. E., Zhang, Y., Beg, M. S., Wilkie, T. M., Lorens, J. B., et al. (2021) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-20-0860 · Cited by 36
Self-citationCombinatorial Gli activity directs immune infiltration and tumor growth in pancreatic cancer
Scales, M. K., Velez-Delgado, A., Steele, N. G., Schrader, H. E., Stabnick, A. M., Yan, W., Mercado-Soto, N. M., Nwosu, Z., Johnson, C. N., Zhang, Y.-Q., et al. (2022) · PLoS Genetics · doi:10.1371/journal.pgen.1010315 · Cited by 28
Cancer‐associated fibroblasts: Is it a key to an intricate lock of tumorigenesis?
Aden, D., Zaheer, S., Ahluwalia, H., & Ranga, S. (2023) · Cell Biology International · doi:10.1002/cbin.12004 · Cited by 33
Hanley, C. J., & Thomas, G. J. (2021) · Oncotarget · doi:10.18632/oncotarget.27936 · Cited by 33
Zhang, A. M. Y., Chu, K., Daly, B. F., Ruiter, T. J. J., Dou, Y., Yang, J. C. C., de Winter, T. J. J., Chhuor, J., Wang, S., Flibotte, S., et al. (2022) · Cancer & Metabolism · doi:10.1186/s40170-022-00282-z · Cited by 32
Shinkawa, T., Ohuchida, K., & Nakamura, M. (2022) · Cancers · doi:10.3390/cancers14163994 · Cited by 32
Pitter, K. L., Grbovic-Huezo, O., Joost, S., Singhal, A., Blum, M., Wu, K., Holm, M., Ferrena, A., Bhutkar, A. J., Hudson, A., et al. (2022) · Cancer Research · doi:10.1158/0008-5472.can-22-1742 · Cited by 35
Fernández, Á., Casamitjana, J., Holguín-Horcajo, A., Coolens, K., Mularoni, L., Guo, L., Hartwig, O., Düking, T., Vidal, N., Strickland, L. N., et al. (2024) · Gastroenterology · doi:10.1053/j.gastro.2024.06.008 · Cited by 32
The Gustatory Sensory G-Protein GNAT3 Suppresses Pancreatic Cancer Progression in Mice
Hoffman, M. T., Kemp, S. B., Salas-Escabillas, D. J., Zhang, Y., Steele, N. G., The, S., Long, D., Benitz, S., Wei, Y., Margolskee, R. F., et al. (2020) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2020.08.011 · Cited by 31
Yang, K., Yang, T., Yu, J. C., Li, F., & Zhao, X. (2023) · BMC Cancer · doi:10.1186/s12885-023-10675-y · Cited by 31
Zhu, J., Zhang, K., Chen, Y., Ge, X., Wu, J., Xu, P., & Yao, J. J. (2024) · Journal of Translational Medicine · doi:10.1186/s12967-024-05307-3 · Cited by 30
S100 family proteins are linked to organoid morphology and EMT in pancreatic cancer
Low, R. R. J., Fung, K. Y., Gao, H., Preaudet, A., Dagley, L. F., Yousef, J. M., Lee, B., Emery‐Corbin, S. J., Nguyen, P. M., Larsen, R. H., et al. (2023) · Cell Death and Differentiation · doi:10.1038/s41418-023-01126-z · Cited by 29
PRMT1 promotes pancreatic cancer development and resistance to chemotherapy
Ku, B., Eisenbarth, D., Baek, S., Jeong, T.-K., Kang, J., Hwang, D., Noh, M., Choi, C., Choi, S., Seol, T., et al. (2024) · Cell Reports Medicine · doi:10.1016/j.xcrm.2024.101461 · Cited by 30
Pancreatic Cancer–Associated Fibroblasts: Where Do We Go from Here?
Carpenter, E. S., Costa, D. B. V., Hasselluhn, M. C., Maitra, A., Olive, K. P., Cukierman, E., di Magliano, M. P., & Sherman, M. H. (2024) · Cancer Research · doi:10.1158/0008-5472.can-24-2860 · Cited by 28
Self-citationThe plasticity of cancer-associated fibroblasts
Xia, Z., & Wever, O. D. (2025) · Trends in cancer · doi:10.1016/j.trecan.2025.04.012 · Cited by 27
Bansod, S., Dodhiawala, P. B., & Lim, K. (2021) · Cancers · doi:10.3390/cancers13215481 · Cited by 28
Chen, K., Wang, Q., Liu, X., Wang, F., Ma, Y., Zhang, S., Shao, Z., Yang, Y., & Tian, X. (2022) · Genes · doi:10.3390/genes13101760 · Cited by 26
James, C. A., Baer, J. M., Zou, C., Panni, U. Y., Knolhoff, B. L., Hogg, G. D., Kingston, N. L., Kang, L., Lander, V. E., Luo, J. R., et al. (2023) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-21-0946 · Cited by 26
Luo, W., & Zhang, T. (2023) · Cancer Letters · doi:10.1016/j.canlet.2023.216279 · Cited by 25
Wang, C., Hou, Y., Hong, Y., Tai, †. Y.-H., Shen, C., Hou, P., Fu, J.-L., Wu, C.-L., Cheng, S. M., Hwang, D., et al. (2025) · Molecular Cancer · doi:10.1186/s12943-024-02207-4 · Cited by 24
DEMOC: a deep embedded multi-omics learning approach for clustering single-cell CITE-seq data
Zou, G., Lin, Y., Han, T., & Ou-Yang, L. (2022) · Briefings in Bioinformatics · doi:10.1093/bib/bbac347 · Cited by 24
Jiang, Z., Zheng, X., Li, M., & Liu, M. (2023) · Frontiers of Medicine · doi:10.1007/s11684-023-1050-6 · Cited by 24
Zhou, D., & Zheng, L. (2024) · Chinese Medical Journal · doi:10.1097/cm9.0000000000003031 · Cited by 23
Mesenchymal Niches for Digestive Organ Development, Homeostasis, and Disease
Loe, A. K. H., Rao‐Bhatia, A., Kim, J., & Kim, T.-H. (2020) · Trends in Cell Biology · doi:10.1016/j.tcb.2020.11.010 · Cited by 25
Doren, S. R. V. (2022) · Biochemical Society Transactions · doi:10.1042/bst20210640 · Cited by 25
Heterotypic signaling of cancer-associated fibroblasts in shaping the cancer cell drug resistance
Butti, R., Khaladkar, A., Bhardwaj, P., & Prakasam, G. (2023) · Cancer Drug Resistance · doi:10.20517/cdr.2022.72 · Cited by 23
Li, M., Wu, B., Li, L., Lv, C., & Tian, Y. (2023) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2023.188945 · Cited by 23
Du, W., di Magliano, M. P., & Zhang, Y. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.682217 · Cited by 22
Self-citationSaúde-Conde, R., Öztürk, A. A., Stosic, K., Senar, O. A., Navez, J., Bouchart, C., Arsenijevic, T., Flamen, P., & Laethem, J. V. (2024) · Biomedicines · doi:10.3390/biomedicines12030591 · Cited by 20
Pfeifer, E., Burchell, J., Dazzi, F., Sarker, D., & Beatson, R. (2021) · Cells · doi:10.3390/cells10071653 · Cited by 21
Molecular phenotypes and spatial archetypes: A new framework for cancer-associated fibroblasts
Liu, Y., Chen, X., Dai, Y., Jia, Y., Kieffer, Y., Xie, L., Zhou, Z., Tyler, L. A., Kim, A. C., Biffi, G., et al. (2026) · Cancer Cell · doi:10.1016/j.ccell.2026.06.001 · Cited by 19
Self-citationZhou, J., Jiang, Y., Huang, Y., Wang, Q., Kaifi, J. T., Kimchi, E. T., Chabu, C. Y., Liu, Z., Joshi, T., & Li, G. (2021) · Translational Oncology · doi:10.1016/j.tranon.2021.101262 · Cited by 19
A molecular pathway for cancer cachexia-induced muscle atrophy revealed at single-nucleus resolution
Zhang, Y., Santos, M. D., Huang, H., Chen, K., Iyengar, P., Infante, R. E., Polanco, P. M., Brekken, R. A., Cai, C., Caijgas, A., et al. (2024) · Cell Reports · doi:10.1016/j.celrep.2024.114587 · Cited by 21
Self-citationAdvancements in sequencing technologies:
Kazim, I., Gande, T., Reyher, E., Bhutia, K. G., Dhingra, K., & Verma, S. (2024) · Journal of Knowledge Learning and Science Technology · doi:10.60087/jklst.v3.n4.p108 · Cited by 19
Gamradt, P., Thierry, K., Masmoudi, M., Wu, Z., Hernández‐Vargas, H., Bachy, S., Antonio, T., Savas, B., Hussain, Z., Tomasini, R., et al. (2023) · PNAS Nexus · doi:10.1093/pnasnexus/pgad405 · Cited by 18
Chen, S. Y., Kung, H., Espinoza, B., Washington, I., Chen, K., Wang, J., Zlomke, H., Loycano, M., Wang, R., Pickup, M. W., et al. (2024) · JCI Insight · doi:10.1172/jci.insight.182766 · Cited by 19
Cancer-associated fibroblasts as accomplices to confer therapeutic resistance in cancer
Wang, W., Cheng, B., & Yu, Q. (2022) · Cancer Drug Resistance · doi:10.20517/cdr.2022.67 · Cited by 18
Fibroblast heterogeneity in pancreatic ductal adenocarcinoma: Perspectives in immunotherapy
Luong, T., Golivi, Y., Nagaraju, G. P., & El‐Rayes, B. F. (2022) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2022.09.001 · Cited by 18
Exploring the Biology of Cancer-Associated Fibroblasts in Pancreatic Cancer
Bryce, A. S., Dreyer, S. B., Froeling, F. E. M., & Chang, D. K.-F. (2022) · Cancers · doi:10.3390/cancers14215302 · Cited by 19
Chen, K., Ma, Y., Huang, L., Wu, P., Kung, H., Yang, B., Zhang, J., Anders, R. A., Zimmerman, J. W., Zhu, Q. C., et al. (2026) · Gut · doi:10.1136/gutjnl-2025-335683 · Cited by 17
Endocrine Pancreas Development and Dysfunction Through the Lens of Single-Cell RNA-Sequencing
Szlachcic, W. J., Ziojla, N., Kizewska, D. K., Kempa, M., & Borowiak, M. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.629212 · Cited by 19
Hou, Z., Lin, J., Ma, Y., Fang, H., Wu, Y., Chen, Z., Lin, X., Lu, F., Shi, W., Yu, X., et al. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1193791 · Cited by 16
Self-citationGopalan, V., Singh, A., Mehrabadi, F. R., Wang, L., Ruppin, E., Arda, H. E., & Hannenhalli, S. S. (2021) · Cancer Research · doi:10.1158/0008-5472.can-21-0427 · Cited by 17
Current Pathology Model of Pancreatic Cancer
Szymoński, K., Milian-Ciesielska, K., Lipiec, E. W., & Adamek, D. (2022) · Cancers · doi:10.3390/cancers14092321 · Cited by 15
Cephas, A., Hwang, W. L., Maitra, A., Parnas, O., & DelGiorno, K. E. (2023) · Gut · doi:10.1136/gutjnl-2022-329313 · Cited by 15
Self-citationTargeting Aggressive Fibroblasts to Enhance the Treatment of Pancreatic Cancer
Yu, Y., Schuck, K., Frieß, H., & Kong, B. (2020) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2021.1857727 · Cited by 16
Cancer cell immune mimicry delineates onco-immunologic modulation
Gao, R., He, B., Huang, Q., Wang, Z., Yan, M., Lam, E. W. ‐., Lin, S., Wang, B., & Liu, Q. (2021) · iScience · doi:10.1016/j.isci.2021.103133 · Cited by 17
Self-citationCytoglobin attenuates pancreatic cancer growth via scavenging reactive oxygen species
Hoang, D. V., Thủy, L. T. T., Hai, H., Hieu, V. N., Kimura, K., Oikawa, D., Ikura, Y., Dat, N. Q., Hoang, T. H., Sato-Matsubara, M., et al. (2022) · Oncogenesis · doi:10.1038/s41389-022-00389-4 · Cited by 15
Yu, H., Wang, Y., He, M., Chen, Y., Bi, J., Lin, X., & Cui, X. (2026) · Molecular Cancer · doi:10.1186/s12943-026-02617-6 · Cited by 14
Heterogeneity and plasticity of cancer-associated fibroblasts
Pramod, S., Lavon, H., Scherz‐Shouval, R., & Sherman, M. H. (2026) · Nature Cancer · doi:10.1038/s43018-026-01146-x · Cited by 14
A Cancer Cell Cluster Marked by LincRNA MEG3 Leads Pancreatic Ductal Adenocarcinoma Metastasis
Pan, H., Diao, H., Zhong, W., Wang, T., Wen, P., & Wu, C. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.656564 · Cited by 14
Agostini, A., Orlacchio, A., Carbone, C., & Guerriero, I. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.876291 · Cited by 14
Interleukin-1β and cancer immune response
Rébé, C., & Ghiringhelli, F. (2025) · Seminars in Immunology · doi:10.1016/j.smim.2025.102002 · Cited by 13
Yang, D., Moniruzzaman, R., Wang, H., Wang, H., & Chen, Y. (2023) · Cancers · doi:10.3390/cancers15082396 · Cited by 13
Cao, Q., Yang, J., Jiang, L., Yang, Z., Fan, Z., Chen, S., Zhu, S., Yin, L., Wang, H., & Wen, W. (2024) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjae023 · Cited by 13
Chen, G., Chen, B., Wu, Y., Nie, H., Zhong, Z., Yang, S., Qin, R., Kang, W., Zhang, C., Wang, N., et al. (2025) · Molecular Cancer · doi:10.1186/s12943-025-02379-7 · Cited by 15
Metabolic landscape of the healthy pancreas and pancreatic tumor microenvironment
Bonilla, M. E., Radyk, M. D., Perricone, M. D., Elhossiny, A. M., Harold, A. C., Medina-Cabrera, P. I., Kadiyala, P., Shi, J., Frankel, T. L., Carpenter, E. S., et al. (2024) · JCI Insight · doi:10.1172/jci.insight.180114 · Cited by 12
Dynamic Evolution of Fibroblasts Revealed by Single-Cell RNA Sequencing of Human Pancreatic Cancer
Dimitrieva, S., Harrison, J. M., Chang, J. E., Piquet, M., Mino-Kenudson, M. A., Gabriel, M., Sagar, V., Horn, H., Lage, K., Kim, J., et al. (2024) · Cancer Research Communications · doi:10.1158/2767-9764.crc-23-0489 · Cited by 12
Heterogeneity in Pancreatic Cancer Fibroblasts—TGFβ as a Master Regulator?
Watt, D. M., & Morton, J. P. (2021) · Cancers · doi:10.3390/cancers13194984 · Cited by 12
MUC16 and TP53 family co-regulate tumor-stromal heterogeneity in pancreatic adenocarcinoma
Chirravuri‐Venkata, R., Dam, V., Nimmakayala, R. K., Alsafwani, Z. W., Bhyravbhatla, N., Lakshmanan, I., Ponnusamy, M. P., Sushil Kumar, K., Jain, M., Ghersi, D., et al. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1073820 · Cited by 12
Kou, Z., Liu, C., Zhang, W., Sun, C., Liu, L., & Zhang, Q. (2024) · International Journal of Oncology · doi:10.3892/ijo.2024.5642 · Cited by 11
Eicosanoids in the Pancreatic Tumor Microenvironment—A Multicellular, Multifaceted Progression
Gubbala, V. B., Jytosana, N., Trinh, V. Q., Maurer, H. C., Naeem, R. F., Lytle, N. K., Ma, Z., Zhao, S., Lin, W., Han, H., et al. (2022) · Gastro Hep Advances · doi:10.1016/j.gastha.2022.02.007 · Cited by 11
Greco, L., Rubbino, F., & Laghi, L. (2022) · Cancers · doi:10.3390/cancers14235797 · Cited by 13
Fu, Y., Li, M., Wu, S., Wang, J., & Wang, S. (2026) · Cell Death and Disease · doi:10.1038/s41419-026-08685-2 · Cited by 11
Spatially organized cellular communities shape functional tissue architecture in the pancreas
Torres-Cano, A., Darrigrand, J.-F., Herrera-Oropeza, G. E., Goss, G., Willnow, D., Salowka, A., Ma, S., Chitnis, D., Rouault, M., Vigilante, A., et al. (2025) · Science Advances · doi:10.1126/sciadv.adx5791 · Cited by 11
Mao, Y., Li, Y., Zheng, Z., Xu, Y., Ke, M., He, A., Liang, F., Zhang, K., Wang, X., Gao, W., et al. (2025) · Cell Systems · doi:10.1016/j.cels.2025.101291 · Cited by 9
Hashimoto, A., Handa, H., Hata, S., & Hashimoto, S. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.1005566 · Cited by 9
Complement and Fungal Dysbiosis as Prognostic Markers and Potential Targets in PDAC Treatment
Speth, C., Bellotti, R., Schäfer, G., Rambach, G., Texler, B., Thurner, G. C., Öfner, D., Lass‐Flörl, C., & Maglione, M. (2022) · Current Oncology · doi:10.3390/curroncol29120773 · Cited by 9
Palma, A. M., Vudatha, V., Peixoto, M. L., & Madan, E. (2023) · Advances in cancer research · doi:10.1016/bs.acr.2023.02.005 · Cited by 10
Single-cell multi-omics in the study of digestive system cancers
Zhou, S., Lin, N., Yu, L., Su, X., Liu, Z., Yu, X., Gao, H., Lin, S., & Zeng, Y. (2023) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2023.12.007 · Cited by 9
Unravelling the Complexity of HNSCC Using Single-Cell Transcriptomics
Conde‐López, C., Marripati, D., Elkabets, M., Heß, J., & Kurth, I. (2024) · Cancers · doi:10.3390/cancers16193265 · Cited by 9
Srinivasan, S., Mehra, S., Jinka, S., Bianchi, A., Singh, S. P., Dosch, A. R., Amirian, H., Krishnamoorthy, V., Silva, I. D. C., Patel, M. S., et al. (2025) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2025.101606 · Cited by 9
Yu, X., Zhang, Q., Zhang, S., He, Y., & Guo, W. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.1000447 · Cited by 9
Diab, M., & El‐Rayes, B. F. (2022) · Journal of Cancer Metastasis and Treatment · doi:10.20517/2394-4722.2022.60 · Cited by 10
Zhang, Z., Wang, X., Hamdan, F. H., Likhobabina, A., Patil, S., Aperdannier, L., Sen, M., Traub, J., Neeße, A., Fischer, A., et al. (2023) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2023.01.015 · Cited by 9
Gene expression dynamics in fibroblasts during early-stage murine pancreatic carcinogenesis
Ohri, N., Häußler, J., Javakhishvili, N., Vieweg, D., Zourelidis, A. A., Trojanowicz, B., Hämmerle, M., Esposito, I., Glaß, M., Sunami, Y., et al. (2024) · iScience · doi:10.1016/j.isci.2024.111572 · Cited by 8
Kang, M., Min, C., Devarasou, S., & Shin, J. H. (2025) · APL Bioengineering · doi:10.1063/5.0250502 · Cited by 8
Metadata
- Authors
- Hosein, A. N., Huang, H., Wang, Z., Parmar, K., Du, W., Huang, J., Maitra, A., Olson, E., Verma, U., & Brekken, R. A.
- Affiliations
- The University of Texas MD Anderson Cancer Center (US)
- The University of Texas Southwestern Medical Center (US)
- Corresponding author
- Brekken, Rolf A.
- ORCID
- Venue
- JCI Insight
- Published
- 2019-08-22
- Volume
- 4
- Issue
- 16
- ISSN
- 2379-3708 (ISSN-L)
- PMC
- PMC6777805
- OpenAlex
- W2964097765
- Cited by
- 302
- References
- 58
- Citations by year
- 2026: 22 · 2025: 29 · 2024: 41 · 2023: 64 · 2022: 61 · 2021: 41 · 2020: 39 · 2019: 4
- FWCI
- 15.22
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- JCI Insight (publishedVersion)
- bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- University of Texas Southwestern Medical Center (See comments)
- Topics
- Health Sciences › Medicine › Oncology › Pancreatic and Hepatic Oncology Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Single-cell and spatial transcriptomics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
- Keywords
- pancreatic ductal adenocarcinoma, tumor progression, cellular heterogeneity, epithelial-mesenchymal transition, tumor-associated macrophages, tumor-infiltrating fibroblasts, fibroblast heterogeneity, tumor microenvironment, epigenetic regulation, genetically engineered mouse models, tumor heterogeneity, stromal heterogeneity
- MeSH terms
- Animals, Disease Models, Animal, Fibroblasts, Mice, Inbred C57BL, Mutation, Pancreatic Neoplasms, Gene Expression Regulation, Neoplastic, Sequence Analysis, Genetic Heterogeneity, Genetic Predisposition to Disease, Carcinoma, Pancreatic Ductal, Mice, Epigenomics, Single-Cell Analysis, Transcriptome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
